RK STRATEGIES, INC.

Lobbying for CLEARMIND MEDICINE, INC · Developer of Psychedelics Medicines

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · British Columbia · House · Senate · $10,000.00 income · posted Jul 21, 2025

Lobbying activity 4

Health Issues

Psychedelic Legislation

Defense

Psychedelics legislation National Defense Authorization Act, 2026

Alcohol and Drug Abuse

Psychedelic Legislation

Veterans

Psychedelic legislation

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.